For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited – ...
The raise will support Rivermark’s pivotal trial, while allowing the medtech company to ready its FloStent system for ...
Andera Partners said today that it led a $20 million Series D financing round for urology-focused medical device maker ...
The FloStent™ System Promises to Redefine the BPH Care PathwayParis, France, and Milwaukee, WI, US, May 13, 2026 (GLOBE ...
The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.
Everyday Health on MSN
Should you try a combo drug for hair loss and erectile dysfunction?
Separate prescriptions to treat male pattern baldness and erectile dysfunction are available in one pill. Learn more about ...
Benign Prostatic Hyperplasia Surgical Treatment Market OverviewThe global benign prostatic hyperplasia surgical treatment ...
Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common condition affecting aging men in India. It often ...
For the first time in nearly three decades, new treatments may be on the way for the roughly 80 million Americans who are losing their hair. Experimental drugs are showing promise after years of ...
The Hearty Soul on MSN
Netanyahu reveals he underwent secret prostate cancer treatment
When news first broke that Israeli Prime Minister Benjamin Netanyahu had been treated for prostate cancer without public disclosure, the reaction was immediate. Here was one of the most recognizable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results